(2019)
Candida auris – Steckbrief eines neuen Pilzes.
Deutsches Ärzteblatt Suppl. Perspektiven der Infektiologie & Immunologie 116(1),
29-30.
(Review)

Oliver Kurzai
National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 3641 532-1347 oliver.kurzai@leibniz-hki.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (especially Candida albicans)
- Infection biology of Neisseria meningitidis
Professional Career
Since 2017 | Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
2009-2016 | Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena |
2008 | Habilitation in medical microbiology, University Würzburg |
2006 | Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer) |
2003 | Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg |
2001-2002 | Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg |
2002 | Dr. med., “summa cum laude” University Würzburg |
2001 | Staatsexamen (state examination) in human medicine, University Würzburg |
Awards · Appointments · Scientific Activities
Since 2014 | Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk) |
Since 2013 | Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena |
Since 2012 | Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage) |
Since 2012 | Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM) |
Since 2011 | Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG |
2015-2016 | Speaker of the ZIK Septomics |
2011-2013 | Editor, Journal of Basic Microbiology |
2009 | Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG) |
2008 | Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
2003 | Science award from the Unterfränkische Gedenkjahrstiftung |
2003 | Dissertation award from the medical faculty of the University Würzburg |
2002 | Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Publications
(2019)
A revised species concept for opportunistic Mucor species reveals species-specific antifungal susceptibility profiles.
Antimicrob Agents Chemother 63(8),
e00653-19.
(2019)
A new species concept for the clinically relevant Mucor circinelloides complex.
Persoonia - Molecular Phylogeny and Evolution of Fungi 42,
67-97.
(2019)
Updates on the taxonomy of mucorales with an emphasis on clinically important taxa.
J Fungi (Basel) 5(4),
106.
(Review)
(2019)
Outbreaks of mucorales and the species involved.
Mycopathologia 185(5),
765-781.
(Review)
(2019)
Treatment with etanercept and low monocyte concentration contribute to the risk of invasive aspergillosis in patients post allogeneic stem cell transplantation.
Sci Rep 9(1),
17231.
(2018)
(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): Study protocol for a randomized controlled trial.
Trials 19(1),
472.
(2018)
Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus.
Nat Commun 9(1),
3098.
(2018)
Tintelnotia destructans: Ein neuer Feind vor dem Tore [Tintelnotia destructans: new enemy at the gates].
Ophthalmologe 115(11),
948-950.
(2018)
Candida species.
In: Oxford University Press (ed.) Oxford Textbook of Medical Mycology Chapter 11, pp. 77-79. Oxford University Press.
ISBN: 978019875. (Review)